de Jong PE - Search Results

1

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1989 Aug;36(2):272-9. doi: 10.1038/ki.1989.190. Kidney Int. 1989. PMID: 2550696 Free article. Clinical Trial.

2

Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.

Gansevoort RT, Heeg JE, Vriesendorp R, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Among authors: de jong pe, de zeeuw d. Nephrol Dial Transplant. 1992;7 Suppl 1:91-6. Nephrol Dial Transplant. 1992. PMID: 1337189

3

The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.

de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S28-32. doi: 10.1097/00005344-199219006-00006. J Cardiovasc Pharmacol. 1992. PMID: 1382162 Review.

4

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action.

Heeg JE, de Jong PE, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Clin Sci (Lond). 1991 Sep;81(3):367-72. doi: 10.1042/cs0810367. Clin Sci (Lond). 1991. PMID: 1655338 Clinical Trial.

5

Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition.

Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Kidney Int. 1991 Oct;40(4):734-41. doi: 10.1038/ki.1991.268. Kidney Int. 1991. PMID: 1660550 Free article. Clinical Trial.

6

Mechanism of the antiproteinuric effect of angiotensin-converting enzyme inhibition.

de Zeeuw D, Heeg JE, Stelwagen T, de Jong RJ, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe, de jong rj. Contrib Nephrol. 1990;83:160-5. doi: 10.1159/000418793. Contrib Nephrol. 1990. PMID: 1966072 No abstract available.

7

Angiotensin-I converting enzyme inhibition: clinical effects in chronic renal disease.

de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Am J Kidney Dis. 1991 May;17(5 Suppl 1):85-8. Am J Kidney Dis. 1991. PMID: 2024682 Review. No abstract available.

8

Lisinopril in hypertensive patients with renal function impairment.

de Jong PE, Apperloo AJ, Heeg JE, de Zeeuw D. de Jong PE, et al. Among authors: de zeeuw d. Nephron. 1990;55 Suppl 1:43-8. doi: 10.1159/000186034. Nephron. 1990. PMID: 2161083

9

Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril.

Heeg JE, de Jong PE, Vriesendorp R, de Zeeuw D. Heeg JE, et al. Among authors: de jong pe, de zeeuw d. Am J Nephrol. 1990;10 Suppl 1:94-7. doi: 10.1159/000168201. Am J Nephrol. 1990. PMID: 2175149 Clinical Trial.

10

Atrial natriuretic factor: its (patho)physiological significance in humans.

de Zeeuw D, Janssen WM, de Jong PE. de Zeeuw D, et al. Among authors: de jong pe. Kidney Int. 1992 May;41(5):1115-33. doi: 10.1038/ki.1992.172. Kidney Int. 1992. PMID: 1319517 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters